Wave Life Sciences Ltd.

Wave Life Sciences is a clinical‑stage biotech using its PRISM platform to develop RNA medicines for rare diseases—Huntington’s, Duchenne, alpha‑1 antitrypsin—and obesity, in partnership with GSK, Takeda and Asuragen.

Headquarters: United States (USA)

Wave Life Sciences Ltd. Logo
Company Profile
  • Employees: 287
  • HQ: Singapore
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
WVE Wave Life Sciences Ltd.
Cap: 2.6B
EQUITY NMS USD SG9999014716 Active
📈
Home Login